Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  18 (2024)
Volume  17 (2023)
Volume  16 (2022)
Volume  15 (2021)
Volume  14 (2020)
Volume  13 (2019)
Volume  12 (2018)
Volume  11 (2017)
Volume  10 (2016)
Volume  9 (2015)
Volume  8 (2014)
Volume  7 (2013)
Volume  6 (2012)
Volume  5 (2011)
Volume  4 (2010)
Volume  3 (2009)
Volume  2 (2008)
Volume  1 (2007)
Related articles

VOLUME 16 , ISSUE 2 ( April-June, 2022 ) > List of Articles

Case Report and Literature Review

2D/3D Ultrasound Findings of Uterine Carcinosarcoma: A Case Report and Literature Review

Zorancho Petanovski, Emilija Petanovska Kostova, Irina Prodanova, Tamara Ivkovska, Gligor Dimitrov

Keywords : 2D ultrasound, 3D color Doppler transvaginal ultrasound, Uterine carcinosarcoma

Citation Information : Petanovski Z, Kostova EP, Prodanova I, Ivkovska T, Dimitrov G. 2D/3D Ultrasound Findings of Uterine Carcinosarcoma: A Case Report and Literature Review. Donald School J Ultrasound Obstet Gynecol 2022; 16 (2):148-152.

DOI: 10.5005/jp-journals-10009-1923

License: CC BY-NC 4.0

Published Online: 05-07-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

Uterine carcinosarcoma is an infrequent, yet an invasive malignant tumor of the uterus. We presented the case of a 76-year-old menopausal woman with the first sparse bleeding and ultrasound findings of a large polypoid formation filling the uterine cavity. Ultrasound, specially more advanced techniques as 3D ultrasound and 3D Color Doppler ultrasound provide very useful data not only in the recognition of tumor mass, but also in terms of the structure, differentiation and stage of the malignancy.

PDF Share
  1. Guttmann DM, Li H, Sevak P, et al. The impact of adjuvant therapy on survival and recurrence patterns in women with early-stage uterine carcinosarcoma: a multi-institutional study. Int J Gynecol Cancer 2016;26(1):141–148. DOI: 10.1097/IGC.0000000000000561
  2. Ravishankar D, Smith A, Avril S, et al. Uterine carcinosarcoma: a primer for radiologists. Abdom Radiol (NY) 1997;44(8): 2874–2885. DOI: 10.1007/s00261-019-02038-8
  3. Denschlag D, Thiel FC, Ackermann S, et al. Sarcoma of the uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015). Geburtshilfe Frauenheilkd 2015;75(10):1028–1042. DOI: 10.1055/s-0035-1558120
  4. Villena-Heinsen C, Diesing D, Fischer D, et al. Carcinosarcomas—a retrospective analysis of 21 patients. Anticancer Res 2006;26(6C):4817–4823. PMID: 17214346.
  5. El-Nashar A, Mariani A. Uterine carcinosarcoma. Clin Obstet Gynecol 2011;54(2):292–304. DOI: 10.1097/GRF.0b013e31821ac635
  6. Haldorsen IS, Salvesen HB. What is the best preoperative imaging for endometrial cancer? Curr Oncol Rep 2016;18(4):25. DOI: 10.1007/s11912-016-0506-0
  7. Epstein E, Fischerova D, Valentin L, et al. Ultrasound characteristics of endometrial cancer as defined by International Endometrial Tumor Analysis (IETA) consensus nomenclature: prospective multicenter study. Ultrasound Obstet Gynecol 2018;51(6):818–828. DOI: 10.1002/uog.18909
  8. Bourgioti C, Chatoupis K, Tzavara C, et al. Predictive ability of maximal tumor diameter on MRI for high-risk endometrial cancer. Abdom Radiol (NY) 2016;41(12):2484–2495. DOI: 10.1007/s00261-016-0927-0
  9. Colombo N, Creutzberg C, Amant F, et al. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. Ann Oncol 2016;27(1):16–41. DOI: 10.1093/annonc/mdv484
  10. Epstein E, Valentin L. Gray-scale ultrasound morphology in the presence or absence of intrauterine fluid and vascularity as assessed by color Doppler for discrimination between benign and malignant endometrium in women with postmenopausal bleeding. Ultrasound Obstet Gynecol 2006;28(1):89–95. DOI: 10.1002/uog.2782
  11. Leone FP, Timmerman D, Bourne T, et al. Terms, definitions and measurements to describe the sonographic features of the endometrium and intrauterine lesions: a consensus opinion from the International Endometrial Tumor Analysis (IETA) group. Ultrasound Obstet Gynecol 2010;35(1):103–112. DOI: 10.1002/uog.7487
  12. Brierley JD, Gospodarowicz MK, Wittekind C. Union for International Cancer Control (UICC). TNM Classification of Malignant Tumours. 8th ed. John Wiley & Sons; 2017.
  13. Prat J. FIGO staging for uterine sarcomas. Int J Gynaecol Obstet 2009;104(3):177–178. DOI: 10.1016/j.ijgo.2008.12.008
  14. Kurjak A, Kupesic S, Shalan H, et al. Uterine sarcoma: a report of 10 cases studied by transvaginal color and pulsed Doppler sonography. Gynecol Oncol 1995;59(3):342–346. DOI: 10.1006/gyno.1995.9965
  15. Kurjak A, Zalud I. The characterization of uterine tumors by transvaginal color Doppler. Ultrasound Obstet Gynecol 1991;1(1):50–52. DOI: 10.1046/j.1469-0705.1991.01010050.x. PMID: 1279710
  16. Stefansson IM, Salvesen HB, Akslen LA. Vascular proliferation is important for clinical progress of endometrial cancer. Cancer Res 2006;66(6):3303–3309. DOI: 10.1158/0008-5472.CAN-05-1163
  17. Zhao F, Xu Y, Zhang H, et al. Ultrasonographic findings of uterine carcinosarcoma. Gynecol Obstet Invest 2019;84(3): 277–282. DOI: 10.1159/000481885
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.